financetom
Business
financetom
/
Business
/
China Vanke's first public commercial REIT falls in early trade on debut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China Vanke's first public commercial REIT falls in early trade on debut
Apr 29, 2024 7:33 PM

SHANGHAI (Reuters) - China Vanke's first public commercial real estate investment products fell as much as 3% in early trade on their debut on Tuesday, reflecting caution towards China's second-largest developer amid a prolonged property market downturn.

The CICC-SCPG Consumption Infrastructure real estate investment trust (REIT) listed in Shenzhen is backed by shopping centres owned by SCPG Holdings, the commercial property platform of Vanke.

The listing came one-and-a-half months after the other three REITs were approved in the same batch. State-backed Vanke is China's second-biggest property developer by sales and is facing short-term liquidity pressures and operational difficulties.

Vanke's onshore shares have slumped 28% since the start of the year, and are hovering near the lowest levels since 2014.

The launch of such REITs comes after China expanded the scope of REITs last year to commercial properties as part of the efforts to prop up a battered property sector. The REITs would allow investor funds to flow to property owners while also giving developers an opportunity to exit their projects.

Around 3.26 billion yuan ($449.88 million) was raised via the issuance of this REIT, but the fresh funds are still small compared to Vanke's cash burn.

"We are concerned by the pace of cash position decline which is at 5.6 billion yuan per month," John Lam, property analyst at UBS, wrote in a note.

With its total cash position of 83.1 billion yuan as of March 2024, the current cash levels can only support 15 months' cash outflow, if the property market and Vanke's debt refinancing market remain at current levels, Lam said.

Shenzhen Metro Group, a state-owned entity and the largest shareholder of Vanke, subscribed to 29.8% of the units of the REIT.

Vanke on Monday reported a second consecutive quarterly loss in the January to March period and a drop in its cash levels, after revenue and margins fell sharply.

After tumbling 28% in 2023, the CSI REITs Index has climbed roughly 7% this year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved